| Naming products | Article number | SCI information |
| hiPSC/hESC Medium-ncTarget | RP01020 | Embryonic Stem Cell Derived Small Extracellular Vesicles Modulate Regulatory T Cells to Protect against Ischemic Stroke 2021. Yuguo Xia,et al. ACS Nano(IF 18.027). |
| A splenic-targeted versatile antigen courier: iPSC wrapped in coalescent erythrocyte-liposome as tumor nanovaccine 2021.Yuewen Zhai,et al.Science Advances(IF 14.957). |
||
| miR143-3p–Mediated NRG-1–Dependent Mitochondrial Dysfunction Contributes to Olanzapine Resistance in Refractory Schizophrenia 2022. Jing Sun,et al.Biological Psychiatry(IF 12.81). |
||
| hiPSC/hESC Medium-ncEpic | RP01001 | Base editing-mediated splicing correction therapy for spinal muscular atrophy 2020. Xiang Lin, et al. Cell Research(IF 46.297). |
| Disruption of splicing-regulatory elements using CRISPR/Cas9 to rescue spinal muscular atrophy in human iPSCs and mice 2019.Jinjing Li，et al.National Science Review(IF 23.178). |
||
| ESC-sEVs Rejuvenate Senescent Hippocampal NSCs by Activating Lysosomes to Improve Cognitive Dysfunction in Vascular Dementia 2020. Guowen Hu, et al. Advanced Science(IF 17.521). |
||
| Vitronectin | RP01002 | Base editing-mediated splicing correction therapy for spinal muscular atrophy 2020. Xiang Lin, et al.. Cell Research(IF 46.297). |
| Embryonic Stem Cell Derived Small Extracellular Vesicles Modulate Regulatory T Cells to Protect against Ischemic Stroke 2020. Yuguo Xia, et al.. ACS Nano(IF 18.027). |
||
| ESC‐sEVs Rejuvenate Senescent Hippocampal NSCs by Activating Lysosomes to Improve Cognitive Dysfunction in Vascular Dementia 2020. Guowen Hu, et al.. Advanced Science(IF 17.521). |
||
| ncLaminin511 | RP01025 | Generation of induced pluripotent stem cell PLAFMCi002-A derived from peripheral blood mononuclear cells of polycystic kidney disease patient with PKD1 mutation 2020. Tao Wang , et al. Stem Cell Research(IF 1.587). |
| Generation of an induced pluripotent stem cell line BIOi002-A from a patient with autosomal dominant optic atrophy 2021. Xiaohui Zhang , et al. Stem Cell Research(IF 1.587). |
||
| Generation of an induced pluripotent stem cell line HUSTTJi001-A from a Moyamoya disease patient with RNF213 gene mutation 2021. Zhijuan Mao , et al. Stem Cell Research(IF 1.587). |
||
| hPSC Dissociation Buffer | RP01007 | Human ESC-sEVs alleviate age-related bone loss by rejuvenating senescent bone marrow-derived mesenchymal stem cells 2020. Liangzhi Gong, et al. Journal of Extracellular Vesicles(IF 17.337). |
| Generation of refractory schizophrenia patient-derived induced pluripotent stem cell line UJSi001-A 2020. Sun, Jing , et al. Stem Cell Research(IF 1.587). |
||
| Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation 2020. He Shan , et al. Stem Cell Research(IF 1.587). |
||
| Solase | RP01021 | Generation of induced pluripotent stem cell PLAFMCi002-A derived from peripheral blood mononuclear cells of polycystic kidney disease patient with PKD1 mutation 2020. Tao Wang , et al. Stem Cell Research(IF 1.587). |
| hiPSC/hESC Cryopreservation Medium | RP01003 | Establishment of an induced pluripotent stem cell line from a patient with hereditary transthyretin amyloidosis carrying transthyretin (TTR) mutation p.Phe53Val 2020. He Shan, et al. Stem Cell Research(IF 1.587). |
| Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation 2020. He Shan , et al. Stem Cell Research(IF 1.587). |
||
| Generation of an induced pluripotent stem cell (iPSC) line (THSJTUi001-A) from a Wilson's disease patient harboring a homozygous Arg778Leu mutation in ATP7B gene 2020. Wang, Shu Hong , et al. Stem Cell Research(IF 1.587). |
||
| hiPSC/hESC Nucleofection Buffer | RP01005 | Base editing-mediated splicing correction therapy for spinal muscular atrophy 2020. Xiang Lin, et al.. Cell Research(IF 46.297). |
| Rock inhibitor-Blebbistatin | RP01008 | Transplantation of GMP-grade human iPSC-derived retinal pigment epithelialcells in rodent model- the first pre-clinical study for safety and efficacy in China Hang Zhang,et al.Ann Transl Med 2021(IF 3.616). |
| Establishment of an induced pluripotent stem cell line from a patient with hereditary transthyretin amyloidosis carrying transthyretin (TTR) mutation p.Phe53Val 2020. He Shan, et al. Stem Cell Research(IF 1.587). |
||
| Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation 2020. He Shan , et al. Stem Cell Research(IF 1.587). |
||
| ncMission hMSC Medium | RP02010 | A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis 2021. Yongzhi Cui, et al. Bioactive Materials(IF 16.874). |
| Small extracellular vesicles secreted by human iPSC-derived MSC enhance angiogenesis through inhibiting STAT3dependent autophagy in ischemic stroke 2020. Yuguo Xia, et al. Stem Cell Research & Therapy(IF 8.079). |
||
| Systemic proteomics and miRNA profile analysis of exosomes derived from human pluripotent stem cells 2022. Youkun Bi, et al. Stem Cell Research & Therapy(IF 8.079) |
||
| hMSC-Osteogenic Differentiation Kit | RP02014-C | Changes in the hepatic differentiation potential of human mesenchymal stem cells aged in vitro 2022. Sang Luo, et al.Annals of Translational Medicine(IF 3.616). |
| hMSC-Adipogenic Differentiation Kit | RP02014-A | Changes in the hepatic differentiation potential of human mesenchymal stem cells aged in vitro 2022. Sang Luo, et al.Annals of Translational Medicine(IF 3.616). |
| hPSC-RPE Differentiation kit | RP01016 | Transplantation of GMP-grade human iPSC-derived retinal pigment epithelialcells in rodent model- the first pre-clinical study for safety and efficacy in China Hang Zhang,et al.Ann Transl Med 2021(IF 3.616). |
| hiPSC-Male/Female | RC01001 | Establishment of Human Pluripotent Stem Cell-Derived Skin Organoids Enabled Pathophysiological Model of SARS-CoV-2 Infection 2021.Jie Ma, et al.Advanced Science(IF 17.521). |
| A splenic-targeted versatile antigen courier iPSC wrapped in coalescent erythrocyte-liposome as tumor nanovaccine. 2021.Yuewen Zhai,et al.Science Advances(IF 14.957). |
||
| Tfcp2l1 safeguards the maintenance of human embryonic stem cell self-renewal. 2018. Sun, Hongwei, et al. Journal of Cellular Physiology(IF 6.513). |
||
| Primary hMSC | RC02003 | Bioenergetic Crosstalk between Mesenchymal Stem Cells and various Ocular Cells through the intercellular trafficking of Mitochondria 2020. Dan Jiang,et al. Theranostics(IF 11.6). |
| Changes in the hepatic differentiation potential of human mesenchymal stem cells aged in vitro 2022. Sang Luo, et al.Annals of Translational Medicine(IF 3.616). |
||
| Dispersible and dissolvable porous microcarrier tablets enable efficient large scale hMSC expansion 2020. Xiaojun Yan, et al. Tissue Engineering Part C: Methods(IF 3.273). |
||
| hPSC-NPC | RC01006 | Naphthalenephenylalanine-phenylalanine-glycine-arginine-glycine-aspartic promotes self-assembly of nephron progenitor cells in decellularized scaffolds to construct bioengineered kidneys 2021. Guangrui Geng, et al. Materials Science & Engineering C-Materials for Biological Applications(IF 8.457). |
| hPSC-RPE | RC01007 | Transplantation of GMP-grade human iPSC-derived retinal pigment epithelial cells in rodent model- the first pre-clinical study for safety and efficacy in China 2021. Hang Zhang, et al.. Ann Transl Med(IF 3.616). |